Lipid-lowering properties of protein-rich mucuna product

被引:0
|
作者
Ngatchic J.T.M. [1 ]
Njintang N.Y. [2 ]
Bernard C. [3 ]
Oben J. [4 ]
Mbofung C.M. [1 ]
机构
[1] Department of Food Science and Nutrition, National School of Agro-industrial Science, P.O. Box 455, Ngaoundere
[2] Department of Biological Sciences, Faculty of Sciences, University of Ngaoundere, P.O. Box 454, Ngaoundere
[3] Industrial school of Biology, EBInnov Laboratory, 32 boulevard du port, 95094 Cergy, Pontoise Cedex
[4] Department of Biochemistry, Faculty of Sciences, University of Yaounde, P.O. Box 812, Yaounde
关键词
Cholesterol; Oxidative stress; Protein-rich mucuna product; Steatosis; Triglycerides;
D O I
10.1186/s41110-016-0003-0
中图分类号
学科分类号
摘要
Background: The objective of this study is to evaluate the effect of protein-rich mucuna product (PRMP) on lipid parameters of hyperlipidemic rats. Methods: Hyperlipidemia was induced in male rats for 3 weeks through high-fat diet. After induction, 30 hyperlipidemic rats were divided into five groups of six rats: control group (CG) received casein and four groups received PRMP as protein source at different proportions: 8.2, 16.4, 24.6, and 32.8 % corresponding, respectively, to 25, 50, 75, and 100 % substitution of casein in the diet for 3 weeks. Lipid and oxidative stress parameters of rats were assessed. Results: There were no significant differences in food intake and body weight loss among the experimental groups. The concentrations of the serum low-density lipoprotein cholesterol, total cholesterol, and triglycerides were lower in groups fed on PRMP 50, 75, and 100 % than in the CG group (p < 0.05). Histological analysis of the liver revealed that animals fed on PRMP diets presented a lower level of steatosis than the CG group. The most significant reduction of lipid parameters was obtained when PRMP was used as unique source of protein (PRMP 100 %). PRMP also influenced oxidative stress parameters as evidenced by a decrease in malondialdehyde and an increase in catalase and superoxide dismutase. Conclusions: These findings demonstrated that PRMP exerts hypolipidemic effect; it has a metabolic effect on endogenous cholesterol metabolism and a protector effect on the development of hepatic steatosis. Our results also suggest that PRMP could manage metabolic diseases associated with oxidative stress. © 2016, The Author(s).
引用
收藏
相关论文
共 50 条
  • [31] Lipid-lowering drugs and cataract
    Bezin, J.
    Mansiaux, Y.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 6 - 6
  • [32] Lipid-Lowering Agents and Hepatotoxicity
    Demyen, Michael
    Alkhalloufi, Kawtar
    Pyrsopoulos, Nikolaos T.
    CLINICS IN LIVER DISEASE, 2013, 17 (04) : 699 - +
  • [33] Complementary lipid-lowering therapies
    McDermott, JH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (16) : 1668 - 1671
  • [34] Lipid-lowering therapies in development
    Wierzbicki, A. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 465 - 465
  • [35] Pharmacogenomics of lipid-lowering therapies
    Hu, Miao
    Tomlinson, Brian
    PHARMACOGENOMICS, 2013, 14 (08) : 981 - 995
  • [36] PRESCRIBING LIPID-LOWERING AGENTS
    WHEATLEY, G
    BRITISH JOURNAL OF GENERAL PRACTICE, 1995, 45 (395): : 329 - 329
  • [37] Carcinogenicity of lipid-lowering drugs
    Laws, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (19): : 1480 - 1480
  • [38] The Future of Lipid-Lowering Therapy
    van Zwol, Willemien
    Rimbert, Antoine
    Kuivenhoven, Jan Albert
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
  • [39] Lipid-lowering efficacy of rosuvastatin
    Adams, Stephen P.
    Sekhon, Sarpreet S.
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
  • [40] MECHANISMS OF LIPID-LOWERING AGENTS
    SIRTORI, CR
    MANZONI, C
    LOVATI, MR
    CARDIOLOGY, 1991, 78 (03) : 226 - 235